{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:38:24Z","timestamp":1792640304573,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    <jats:italic>Helicobacter pylori<\/jats:italic>\n                    antibiotic resistance is increasing worldwide, emphasizing the urgent need for more rapid resistance detection prior to the administration of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    eradication regimens. Macrolides and fluoroquinolones are widely used to treat\n                    <jats:italic>H. pylori<\/jats:italic>\n                    . In this study, we aimed to compare the diagnostic performance of A) 23SrDNA qPCR (with melting curve analysis) and an in-house developed\n                    <jats:italic>gyrA<\/jats:italic>\n                    qPCR followed by Sanger sequencing with a commercial IVD-marked hybridization probe assay (for 23SrDNA and\n                    <jats:italic>gyrA<\/jats:italic>\n                    ) using 142 gastric biopsies (skipping culturing) and B) the same two qPCR for 23SrDNA and\n                    <jats:italic>gyrA<\/jats:italic>\n                    (including Sanger sequencing) with whole-genome sequencing (WGS) and phenotypic characterization of clarithromycin and levofloxacin resistance using 76 cultured isolates. The sensitivity of both qPCRs was 100% compared to that of the commercial IVD-marked hybridization probe assay for the detection of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    in gastric biopsies (without resistance testing). The specificity of the qPCR\n                    <jats:italic>gyrA<\/jats:italic>\n                    followed by Sanger sequencing was 100%, indicating that the best sequence identity was always\n                    <jats:italic>H. pylori<\/jats:italic>\n                    . The results show good agreement between molecular tests, especially between qPCR (inclusive Sanger sequencing) and WGS. Discrepancies (concerning mutated or wild type of positive\n                    <jats:italic>H. pylori<\/jats:italic>\n                    gastric biopsies) were observed between Sanger sequencing of the\n                    <jats:italic>gyrA<\/jats:italic>\n                    gene and the corresponding commercial hybridization probe assay, mostly because the high sequence diversity of the\n                    <jats:italic>gyrA<\/jats:italic>\n                    gene even at positions adjacent to the relevant codons of 87 and 91 interfered with obtaining correct results from the hybridization probe assay. Interestingly, we found several mixed sequences, indicating mixed populations in the gastric biopsies (direct detection without culturing). There was a high percentage of both levofloxacin and clarithromycin resistance in gastric biopsies (both between 22% and 29%, direct detection in gastric biopsies). Therefore, we recommend analyzing both targets in parallel. We confirmed that phenotypic resistance is highly correlated with the associated mutations. We concluded that the two qPCR followed by Sanger sequencing of the\n                    <jats:italic>gyrA<\/jats:italic>\n                    gene is a fast, cost-effective and comprehensive method for resistance testing of\n                    <jats:italic>H. pylori<\/jats:italic>\n                    directly in gastric biopsies.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2020.596371","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T19:00:09Z","timestamp":1610046009000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":59,"title":["Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori"],"prefix":"10.3389","volume":"10","author":[{"given":"Konrad","family":"Egli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Risch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Risch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1038\/s41467-019-10050-1","article-title":"Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps","volume":"10","author":"Ailloud","year":"2019","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e12512","DOI":"10.1111\/hel.12512","article-title":"Real-time PCR for Helicobacter pylori diagnosis","volume":"23","author":"B\u00e9n\u00e9jat","year":"2018","journal-title":"Helicobacter"},{"key":"B3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.cmi.2017.06.025","article-title":"Prospective multicentre clinical study on inter- and intrapatient genetic variability for antimicrobial resistance of Helicobacter pylori","volume":"24","author":"Bilgilier","year":"2018","journal-title":"Clin. Microbiol Infect."},{"key":"B4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.diagmicrobio.2010.03.010","article-title":"Two-decade trends in primary Helicobacter pylori resistance to antibiotics in Bulgaria. Diagnostic microbiology and infectious disease","volume":"67","author":"Boyanova","year":"2010","journal-title":"Diagn. Microbiol Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.3748\/wjg.v16.i31.3865","article-title":"First-line eradication of Helicobacter pylori: Are the standard triple therapies obsolete? A different perspective","volume":"16","author":"Buz\u00e1s","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1128\/JCM.00744-09","article-title":"Evaluation of a new test, GenoType HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori","volume":"47","author":"Cambau","year":"2009","journal-title":"J. Clin. Microbiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jac\/dkr410","article-title":"Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain","volume":"67","author":"Cuadrado-Lav\u00edn","year":"2012","journal-title":"J. Antimicrob Chemother."},{"key":"B8","first-page":"409","article-title":"Worldwide H. pylori antibiotic resistance: A systematic review","volume":"19","author":"de Francesco","year":"2010","journal-title":"J. Gastrointest Liver Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13099-017-0226-5","article-title":"A multicenter prospective study on the diagnostic performance of a new liquid rapid urease test for the diagnosis of Helicobacter pylori infection EK 1548\/2014 EK","volume":"9","author":"Dolak","year":"2017","journal-title":"Gut Pathog"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1093\/nar\/gky1307","article-title":"The core genome m5C methyltransferase JHP1050 (M.Hpy99III) plays an important role in orchestrating gene expression in Helicobacter pylori","volume":"47","author":"Estibariz","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1128\/JCM.00472-13","article-title":"Can molecular methods detect 1% isoniazid resistance in mycobacterium tuberculosis","volume":"51","author":"Folkvardsen","year":"2013","journal-title":"J. Clin. Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1099\/jmm.0.45642-0","article-title":"In vitro activity of fluoroquinolone and the gyrA gene mutation in Helicobacter pylori strains isolated from children","volume":"53","author":"Fujimura","year":"2004","journal-title":"J. Med. Microbiol"},{"key":"B13","first-page":"226","article-title":"Real-Time PCR detection and quantitation of Helicobacter pylori clarithromycin-resistant strains in archival material and correlation with Sydney classification","volume":"26","author":"Gazi","year":"2013","journal-title":"Ann. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"B15","first-page":"687","article-title":"A year\u2019s review of bacterial pneumonia at the central hospital of Lucerne, Switzerland","volume":"131","author":"Hug","year":"2001","journal-title":"Swiss Med. Wkly"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3099-4","article-title":"The magnitude of antibiotic resistance to Helicobacter pylori in Africa and identified mutations which confer resistance to antibiotics : systematic review and meta- analysis","author":"Jaka","year":"2018"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12702","article-title":"Evaluation of the Allplex TM H pylori and ClariR PCR Assay for Helicobacter pylori detection on gastric biopsies","author":"Jehanne","year":"2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ijid.2019.05.028","article-title":"International Journal of Infectious Diseases Population-level macrolide consumption is associated with clarithromycin resistance in Helicobacter pylori : An ecological analysis","volume":"85","author":"Kenyon","year":"2019","journal-title":"Int. J. Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/jac\/48.suppl_1.77","article-title":"Recomendations for susceptibility tests on fastidous organisms and requiring special handling","volume":"48","author":"King","year":"2001","journal-title":"J. Antimicrobial. Chemother."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010053","article-title":"Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori","volume":"8","author":"Lauener","year":"2019","journal-title":"J. Clin. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12641","article-title":"Review : Diagnosis of Helicobacter pylori infection","volume":"24","author":"Makristathis","year":"2019","journal-title":"Helicobacter"},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of helicobacter pylori infection-the Maastricht V\/Florence consensus report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1099\/mgen.0.000344","article-title":"Trends in Helicobacter pylori resistance to clarithromycin : from phenotypic to genomic approaches","volume":"6","author":"Marques","year":"2020","journal-title":"Microbial. Genomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/gutjnl-2012-302254","article-title":"Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption","volume":"62","author":"Megraud","year":"2013","journal-title":"Gut"},{"key":"B26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1756283X11432492","article-title":"The challenge of Helicobacter pylori resistance to antibiotics: The comeback of bismuth-based quadruple therapy","volume":"5","author":"M\u00e9graud","year":"2012","journal-title":"Therap Adv. Gastroenterol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2017.09.014","article-title":"A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene","volume":"90","author":"Redondo","year":"2018","journal-title":"Diagn. Microbiol Infect. Dis."},{"key":"B28","first-page":"363","article-title":"High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy","volume":"21","author":"Saracino","year":"2012","journal-title":"J. Gastrointest Liver Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1053\/j.gastro.2018.07.007","article-title":"CLINICAL \u2014 ALIMENTARY TRACT Prevalence of Antibiotic Resistance in Helicobacter pylori: Gastroenterology","volume":"155","author":"Savoldi","year":"2018","journal-title":"Helicobacter"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1128\/JCM.42.10.4512-4518.2004","article-title":"Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens","volume":"42","author":"Schabereiter-Gurtner","year":"2004","journal-title":"J. Clin. Microbiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9912","DOI":"10.3748\/wjg.v20.i29.9912","article-title":"Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance","volume":"20","author":"Smith","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/apt.13497","article-title":"Review article: The global emergence of Helicobacter pylori antibiotic resistance","volume":"43","author":"Thung","year":"2016","journal-title":"Aliment Pharmacol. Ther."},{"key":"B33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/38792","article-title":"Erratum: The complete genome sequence of the gastric pathogen Helicobacter pylori (Nature (1997) 388 (539-547))","volume":"389","author":"Tomb","year":"1997","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/jac\/dkp003","article-title":"Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany","volume":"63","author":"Wueppenhorst","year":"2009","journal-title":"J. Antimicrob Chemother."},{"key":"B35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s15010-005-4071-y","article-title":"Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media","volume":"33","author":"Yuen","year":"2005","journal-title":"Infection"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03331.x","article-title":"Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy","volume":"25","author":"Zullo","year":"2007","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.596371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T03:31:37Z","timestamp":1610249497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2020.596371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":36,"alternative-id":["10.3389\/fcimb.2020.596371"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2020.596371","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]},"article-number":"596371"}}